Vaxart (VXRT) Misses Q4 EPS by 23c

Vaxart (NASDAQ: VXRT) reported Q4 EPS of ($0.33), $0.23 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $28.7 million versus the consensus estimate of $20.77 million.

For earnings history and earnings-related data on Vaxart (VXRT) click here.

You May Also Be Interested In

• Trump Bought At Least $100,001 In Palantir Shares, Disclosure Shows - Bloomberg
• Tessenderlo Group to take 20% stake in FMC for $400 million
• Constellation Brands (STZ) Tops Q1 EPS by 18c